Related Experiment Videos
Contrast nephropathy : an evidence-based approach to prevention
David E Kandzari1, Abdallah G Rebeiz, Andrew Wang
1Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Summary
Contrast-induced nephropathy (CIN) affects 2-10% of patients receiving contrast agents. Intravenous hydration and N-acetylcysteine are recommended for preventing CIN in high-risk individuals.
Area of Science:
- Nephrology
- Radiology
- Pharmacology
Background:
- Contrast-induced nephropathy (CIN) is a significant complication of intravascular radiographic contrast agents, affecting 2-10% of patients.
- CIN results from decreased renal blood flow and direct tubular toxicity, leading to substantial morbidity and mortality.
- Risk factors include pre-existing renal dysfunction, diabetes, heart failure, dehydration, and concurrent nephrotoxic drug use.
Purpose of the Study:
- To review current literature on contrast-induced renal dysfunction.
- To present an evidence-based strategy for preventing CIN.
Main Methods:
- Review of contemporary scientific literature on contrast-induced nephropathy.
- Analysis of evidence for various preventive strategies, including hydration and pharmacologic interventions.
Main Results:
- Intravenous hydration is a proven method to reduce CIN incidence in high-risk patients.
- Many pharmacologic interventions (e.g., calcium channel antagonists, dopamine) have shown disappointing results.
- N-acetylcysteine demonstrates potential benefit in high-risk patients with baseline renal dysfunction, alongside hydration.
Conclusions:
- Intravenous hydration is a cornerstone of CIN prevention.
- N-acetylcysteine should be strongly considered for high-risk patients with baseline renal dysfunction.
- Further research may refine pharmacologic approaches to CIN prevention.